AEGiS-WSJ: EU Approves HIV Drug For Marketing in Europe Wall Street JournalImportant note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
Click here to return to Wall Street Journal main menu




DonateNow



EU Approves HIV Drug For Marketing in Europe

Wall Street Journal - January 23, 1998

Agouron Pharmaceuticals Inc., San Diego, said the European Commission approved Viracept, its drug for HIV, for marketing to adults and children in Europe. Agouron and its partner, Japan Tobacco Inc. 's pharmaceutical unit, previously gave rights to a unit of Roche Holding AG of Switzerland to market the drug in Europe and territories outside North America and Asia. Agouron said the drug, already approved for sale in Switzerland, will be available in Germany, France and the U. K. in the first quarter of 1998, followed by other European countries. The U.S. Food and Drug Administration approved Viracept in March, and Agouron said Viracept now holds a 31% share of the U.S. market for protease-inhibitor drugs. Agouron shares fell $1.875 to $31.375 in Nasdaq Stock Market trading.


980123
WJ980102

Copyright © 1998 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .